- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
Patent holdings for IPC class A61P 21/00
Total number of patents in this class: 5927
10-year publication summary
|
188
|
300
|
415
|
406
|
443
|
596
|
603
|
559
|
493
|
324
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dyne Therapeutics, Inc. | 259 |
103 |
| Research Institute at Nationwide Children's Hospital | 636 |
88 |
| Société des Produits Nestlé S.A. | 10107 |
87 |
| Sarepta Therapeutics, Inc. | 387 |
72 |
| Novartis AG | 10263 |
50 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3219 |
48 |
| Avidity Biosciences, Inc. | 179 |
47 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3337 |
45 |
| Osaka University | 3269 |
43 |
| Centre National de La Recherche Scientifique | 11016 |
42 |
| The Regents of the University of California | 20720 |
35 |
| President and Fellows of Harvard College | 6091 |
29 |
| Genethon | 255 |
28 |
| Scholar Rock, Inc. | 137 |
27 |
| F. Hoffmann-La Roche AG | 7836 |
26 |
| Takeda Pharmaceutical Company Limited | 2715 |
25 |
| Edgewise Therapeutics, Inc. | 65 |
25 |
| Kyoto University | 2898 |
24 |
| Sorbonne Universite | 1394 |
22 |
| The Trustees of the University of Pennsylvania | 4414 |
21 |
| Other owners | 5040 |